La diversidad nos hace más fuertes. Creemos en un entorno donde cada persona pueda ser auténtica y sentirse valorada. Reafirmamos nuestro compromiso con la inclusión y el respeto, porque cuando apoyamos la diversidad, creamos un impacto positivo en la salud y en la sociedad. #AbbVieLife
关于我们
AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world. We aim to address complex health issues and enhance people's lives through our core therapeutic areas: immunology, oncology, neuroscience, eye care, aesthetics and other areas of unmet need. Learn more about us at www.abbvie.com and review our community guidelines at https://www.abbvie.com/social-media-community-guidelines.html.
- 网站
-
https://www.abbvie.com
AbbVie的外部链接
- 所属行业
- 制药业
- 规模
- 超过 10,001 人
- 总部
- North Chicago，Illinois
- 类型
- 上市公司
- 领域
- Biopharmaceutical、Biotechnology、Innovation、Research and Development、Manufacturing、Biotherapeutics、Oncology、Immunology、Virology、Neuroscience、Womens Health、Aesthetics和Eye Care
地点
AbbVie员工
动态
-
? Wenn morgens um 7:30 Uhr zahlreiche Landtagsabgeordnete, Staatssekret?re, Vertreterinnen und Vertreter der Kommunalpolitik sowie aus Verb?nden einer Einladung von AbbVie folgen, dann muss es ein besonders interessantes Thema mit hochkar?tigen G?sten sein! ?? Gemeinsam mit Prof. Dr. Stefanie Dimmeler von der Goethe-Universit?t Frankfurt, Francesco Grioli von der Industriegewerkschaft Bergbau, Chemie, Energie, Prof. Dr. Dennis Ostwald vom WifOR Institute und unserer Business Unit Direktorin in der Onkologie Viviane Petermann diskutierte unser Moderator Rüdiger Rein, Head of Government Affairs, darüber, wie wir den Pharmastandort Hessen fit für die Zukunft machen. Den Impuls für die spannende Diskussion lieferte unser Sprecher der Gesch?ftsführer, Thibault Massart. Panel und Teilnehmer*innen waren sich einig: Im engen Schulterschluss zwischen Forschung, Industrie und Politik k?nnen wir den Zugang zu Innovationen sichern und den Pharmastandort Deutschland wie auch Hessen langfristig st?rken. Wir danken allen, die sich heute an der Diskussion beteiligt haben, u.a.: Elke Barth; Oliver Franz; Dennis Friedrich; Daniela Georgi; Silas Gottwald; Nina Heidt-Sommer; Wolfgang Hendricks; Susanne Hoffmann-Fessner; Alexander Hofmann; Andreas Hofmeister; Bijan Kaffenberger; Dr. Christian Kurz; Dominik Leyh; Prof. Dr. Johannes Luderschmidt; Dirk Meyer; Katrin Ostwald; Sylvia Schob; Eleftherios Tsiridis; Aman Yoseph; Sebastian Sack; Sebastian Wachtarz; Wolfgang Reinert; Marcel Gies; German Chemical Industry Association VCI; House of Pharma & Healthcare
-
-
???? Somos um Great Place to Work! Mais do que um reconhecimento, este prémio é um reflexo da nossa cultura e das pessoas incríveis que fazem da AbbVie um dos melhores lugares para trabalhar. Pelo 12o ano consecutivo, fomos distinguidos pelo Great Place to Work? Portugal e isso só é possível gra?as à dedica??o e ao espírito de equipa de cada um. As caras que representam um Great Place to Work s?o as mesmas que fazem dele uma realidade todos os dias. Obrigado a todos! ?? #AbbVieLife #GreatPlacetoWork #BestWorkplaces #mlpt2025
-
El linfoma B difuso de células grandes (#LBDCG) es uno de los tipos más agresivos de linfoma no Hodgkin, con un 30-40% de pacientes que recaen tras el tratamiento inicial. En AbbVie en Espa?a, trabajamos para que la innovación en oncohematología marque la diferencia en sus vidas, mejorando el abordaje y manejo de la enfermedad para los pacientes que viven con ella. Porque para ellos, queda mucho por hacer, mucho por vivir.
-
A culture of #innovation helps drive our ability to create new medicines and treatment approaches for a healthier world. That’s why we’re honored to be named to Fortune's America's Most Innovative Companies list for the third year in a row. Learn more about our approach to science and innovation: https://bit.ly/4j3BhXo
-
-
NEWS: At this year’s American Association for Cancer Research (AACR) Annual Meeting, we’re presenting new data showcasing our early pipeline and research in oncology to help advance the science across a range of cancers with high unmet needs. Read more: https://bit.ly/43VlPs8 #AACR25 #SolidTumors [Video description: On-screen text reads, “Oncology News.”]
-
Hear Jenina, from our commercial team, talk about her career journey with us, the empowerment she feels bringing her authentic self to work every day and her advice for other working women. Interested in a #career with us? Learn more: https://bit.ly/4l1SL8E #WomensHistoryMonth #AbbVieLife [Video description: An AbbVie employee shares her career journey, how she brings her authentic self to work and her advice for women in the workforce.]
-
There’s a need for additional #ColorectalCancer treatment options. When diagnosed in the metastatic phase, median overall survival is approximately one year. Hear how our scientists are working to develop medicines to help improve outcomes for patients: https://bit.ly/3Y34WYJ #ColorectalCancerAwarenessMonth [Video description: A person shares their experience with colorectal cancer and an AbbVie scientific leader shares how we’re working to address patients’ needs.]
-
Fostering an inclusive environment where everyone feels empowered to thrive is core to our values. In recognition of #NeurodiversityCelebrationWeek, hear the perspectives of some of our Ability employee resource group members on the significance of supportive language. #BelongAtAbbVie #ThisIsND [Video description: AbbVie employees share how they feel specific language around neurodiversity has helped create a more positive, inclusive environment for the neurodiverse community.]
-
Through our R&D efforts in precision medicine, we are striving to help address unmet patient needs in colorectal cancer. This Colorectal Cancer Awareness Month, hear from the CEO of the Colorectal Cancer Alliance, Michael Sapienza, as he shares his perspectives. #oncology #colorectalcancer #colorectalcancerawareness Learn more about our oncology research focus areas: https://bit.ly/4hk124F [Video Description: On-screen text reads, “Despite remarkable progress in recent years, significant unmet needs persist in colorectal cancer care. With young-onset diagnoses on the rise, it is more critical than ever to propel cutting-edge research forward through initiatives like Project Cure CRC, driving the development of innovative therapies that improve patient outcomes and transform the future of care. – Michael Sapienza, CEO Colorectal Cancer Alliance”